← Back to Search

Telerehabilitation for Stroke Rehabilitation (Telestroke Trial)

N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have had stroke event (haemorrhagic or ischemic)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion (up to 5 years)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help stroke survivors by providing rehabilitation services through live video sessions, known as telerehabilitation. Telerehabilitation has been explored as a method to provide rehabilitation services to stroke patients, overcoming barriers such as access, cost, and compliance. This approach allows patients to receive care from home, making it easier for them to stick to their rehabilitation plans. The study will compare the outcomes and costs of telerehabilitation with traditional in-person care.

Who is the study for?
This trial is for Canadian stroke survivors who are safe to go home and have mild to moderate independence. They must speak French or English, have a caregiver at home, and have had a recent stroke (hemorrhagic or ischemic). People with severe cognitive decline before the stroke cannot join.
What is being tested?
The study tests if telerehabilitation—remote rehab sessions via technology—with team care plans improves recovery compared to usual care after a stroke. It involves 220 patients receiving this new approach versus 110 getting standard treatment.
What are the potential side effects?
Since the intervention focuses on rehabilitation through technology rather than medication, side effects may include discomfort with tech use or issues related to remote communication rather than physical drug-related side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a stroke before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion (up to 5 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion (up to 5 years) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in patient adherence to stroke rehabilitation plan
Patient adherence to stroke rehabilitation plan (Patient journal)
Patient adherence to stroke rehabilitation plan (Professional perception)
Secondary study objectives
Adverse events
Change in depression state
Change in functional recovery and independence
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: TelerehabilitationExperimental Treatment1 Intervention
A mix of home or rehabilitation center visits, telerehabilitation and interprofessional shared decision making process.
Group II: ControlExperimental Treatment1 Intervention
Usual rehabilitation care (no telerehabilitation, interdisciplinary meetings not systematically organized and/or not involving a complete team of professionals)

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Stroke rehabilitation treatments aim to restore function and improve quality of life by leveraging neuroplasticity, which is the brain's ability to reorganize and form new neural connections. Common treatments include physical therapy, occupational therapy, and speech therapy, which focus on repetitive, task-specific exercises to enhance motor skills, cognitive function, and communication abilities. Telerehabilitation, which involves remote, live treatment sessions with interdisciplinary clinicians, enhances access to these therapies by overcoming geographical barriers and increasing patient engagement. This approach is crucial for stroke rehabilitation patients as it ensures continuity of care, promotes adherence to rehabilitation protocols, and facilitates personalized treatment plans, ultimately leading to better recovery outcomes.
Telerehabilitation Intervention in Patients with COVID-19 after Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,115 Total Patients Enrolled
Université de SherbrookeLead Sponsor
306 Previous Clinical Trials
77,254 Total Patients Enrolled
Université de MontréalOTHER
221 Previous Clinical Trials
103,962 Total Patients Enrolled
Laval UniversityOTHER
434 Previous Clinical Trials
178,308 Total Patients Enrolled

Media Library

Telerehabilitation and team meetings and team care plans Clinical Trial Eligibility Overview. Trial Name: NCT04440215 — N/A
Stroke Rehabilitation Research Study Groups: Control, Telerehabilitation
Stroke Rehabilitation Clinical Trial 2023: Telerehabilitation and team meetings and team care plans Highlights & Side Effects. Trial Name: NCT04440215 — N/A
Telerehabilitation and team meetings and team care plans 2023 Treatment Timeline for Medical Study. Trial Name: NCT04440215 — N/A
~61 spots leftby Dec 2025